GENINVO
Live / Registered — Registered (as of 31 Mar 2026)
What this means for you
Registered since 31 Mar 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99338269
- Registration number
- 8193221
- Mark type
- Stylized text
- Filed
- 14 Aug 2025
- Published for opposition
- 10 Feb 2026
- Registered
- 31 Mar 2026
- Attorney of record
- Matthew Saunders
Goods and services
- Class 035 — Advertising and business services: Business consulting services for pharmaceutical and life sciences companies in the fields of clinical research, clinical trials, and applications for drug approval; Business data analytics and business data management services in the pharmaceutical and life sciences fields of clinical research; Business consulting and management in the field of clinical trials, namely, clinical data management on behalf of pharmaceutical and life sciences companies to assist them with clinical research and clinical trials; Providing independent review of clinical trial data for business purposes
- Class 042 — Scientific and technological services: Providing temporary use of online non-downloadable software and software applications for data management and data analysis in the nature of clinical trial data ingestion, data anonymization, data collaboration, data transformation, predictive data analysis, document review, metadata management, patient data anonymization, and automated reporting; providing temporary use of online non-downloadable software and software applications using artificial intelligence (AI) for data management and data analysis in the nature of clinical trial data ingestion, data anonymization, data collaboration, data transformation, predictive data analysis, document review, metadata management, patient data anonymization, and automated reporting; Custom design of computer application software; Technical support services, namely, cloud managed services in the nature of remote infrastructure management services for migration, configuration, monitoring, and management of cloud computing IT systems and cloud databases; Providing quality control services in the fields of clinical research, clinical trials, and applications for drug approval; Providing independent review of clinical trial data for medical or scientific purposes
Owner
- GenInvo, Inc., Bloomington, IL, US
- GenInvo, Inc., Bloomington, IL, US
- GenInvo, Inc., Bloomington, IL, US
Prosecution history
- 31 Mar 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 31 Mar 2026 — REGISTERED-PRINCIPAL REGISTER
- 10 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Feb 2026 — PUBLISHED FOR OPPOSITION
- 04 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Jan 2026 — EXAMINER'S AMENDMENT ENTERED
- 13 Jan 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 13 Jan 2026 — EXAMINERS AMENDMENT E-MAILED
- 13 Jan 2026 — EXAMINERS AMENDMENT -WRITTEN
- 31 Dec 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 31 Dec 2025 — NON-FINAL ACTION E-MAILED
- 31 Dec 2025 — NON-FINAL ACTION WRITTEN
- 31 Dec 2025 — ASSIGNED TO EXAMINER
- 30 Dec 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED